RECENT WEBINARS
Engineering Precision In Genetic Medicines
Precision genome editing strategies that balance specificity and potency through advanced engineering workflows, AI‑driven optimization, and tailored editor design for clinical genetic medicines.
Using Full DEL Data To Improve Early Compound Decisions
High-throughput screens hold insights beyond individual hits. Examine a broader view of screening data that reveals structure–function patterns to guide smarter compound prioritization.
From DNA To IND In As Little As 6 Months
Discover how an integrated, platform-driven CMC approach can accelerate your antibody program from DNA to IND in as little as six months while reducing risk and maintaining quality and regulatory alignment.
Biologics Tech Transfer & Validation at Scale: A Better Path to GMP
Explore where tech transfer and validation commonly falter, and how disciplined execution helps teams maintain control through PPQ and beyond.
Unlocking The Next Wave Of Cancer Vaccines
Discover how advanced ionizable LNP formulations and scalable manufacturing strategies can accelerate the development and clinical translation of personalized cancer vaccines.
Where Sourcing Meets Science: Smarter Collaboration, Better Outcomes
See how collaboration-driven raw material control reduces variability, improves cell culture performance, and delivers measurable cost and productivity gains in biotherapeutic manufacturing.
OneTeam™: Setting A New Standard for Biotech Program Visibility
An on‑demand session showing how integrated governance and real‑time data boost visibility, collaboration, and control in outsourced gene therapy development.
Less Risk, More Speed -The New Blueprint For Bioconjugate Development
A fireside chat on how integrated development models reduce risk and accelerate bioconjugate timelines from discovery through GMP manufacturing.
Flexible Therapeutic Development: Balancing Speed, Cost, and Process
Microbial development for first‑in‑human studies requires coordinated cell line, fermentation, and purification strategies to accelerate timelines while controlling cost and process robustness.
Accelerating Vector Construction-To-IND: Achieving A 9-Month Timeline Through Integrated Cell Line Development
Uncover how tighter alignment between vector construction and cell banking improved development efficiency, strengthened risk management, and enhanced early-stage program outcomes.
How AI-Enabled Validation Technologies Enable The Predictive Plant
Discover how AI-enabled digital validation shifts manufacturers from reactive compliance to predictive intelligence, connecting validation, asset, and quality data to accelerate digital maturity.
Enhanced Biotherapeutic Protein Expression Using Advanced Vector Systems
Learn how optimized expression vector design and data-driven strategies can significantly enhance product titre, quality, and long-term gene expression stability in GS-CHO cell-based manufacturing.
Translating Stem Cell Programs To GMP
A detailed exploration of challenges in advancing stem cell programs to GMP, highlighting strategies to control variability, strengthen process design, and support reliable clinical‑stage manufacturing.
Where Biologic Stability Programs Fail — And How ICH Q1 Can Help You Get It Right
This session highlights common late-stage risks and discusses how a stronger stability design can support confident IND, BLA, and long-term supply strategies.
Integrated Thinking for Complex FIH Programs
See how deep expertise, integrated thinking, and cross-functional collaboration turn complex molecule challenges into opportunities, strengthening early decisions and improving First‑in‑Human outcomes.
Concept To Market: Scaling And Manufacturing Semi-Solid Topical Drugs
Learn how formulation, processing, and scale‑up choices impact the stability, structure, and performance of semi‑solid topicals while ensuring consistent quality through development.
Selecting A Prefillable Syringe System With Confidence
Discover an advancement in the prefillable syringe market, uniquely integrating the syringe barrel, plunger, and needle shield/tip cap into a fully harmonized, verified system from a single supplier.
Designing Drug Substance Processes For Fill-Finish Compatibility
Integrated KBI and Argonaut solutions streamline drug substance to fill-finish transitions, resolving quality challenges, reducing delays, and accelerating timelines through coordinated processes and practical strategies.
Next-Level Cell Lines: An Integrated Approach To Biologic Innovation
See how AI-driven tools and optimized platforms are accelerating biologics development, delivering high-titer clones in weeks, and paving the way for integrated design of cell lines and genetic systems.
Five Practical Considerations To Move From Concept To Clinic
Learn more about five key factors for advancing targeted in vivo LNP programs, from formulation and targeting strategies to bioanalytical readiness and scalability.
Eliminate Risk From Your Viral Vector Tech Transfers
Explore strategies to simplify viral vector tech transfers, reduce risk, and maintain quality under tight timelines, as well as a case study that demonstrates how to streamline this critical process.
Navigating Regulatory Expectations For Injectable Packaging
Explore insights on extractables, focusing on how they relate to the revised EU GMP Annex 1, new and evolved expectations under USP <382>, and the use of VHP decontamination in aseptic environments.
Raising The Bar In Gene Therapy
Learn how a science-driven and digitally structured approach reduced onboarding timelines for gene therapy from 12 months to just 3, setting a new benchmark in technology transfers.
Extrusion-Based ASD Scale-Up: Performance Through Process Understanding
Explore the formulation and manufacturing considerations for amorphous solid dispersions (ASDs), with a focus on hot melt extrusion (HME) as a scalable and cost-effective technology option.
Streamlining pDNA: Capacity, Complexity, And Cutting-Edge Solutions
Learn how flexible facility design and process innovation are accelerating pDNA manufacturing, as well as key strategies to avoid scale-up pitfalls and meet growing therapeutic demand.
Are You Keeping Pace With Oligo Synthesis Optimization?
The rapidly expanding oligo market demands optimized RNA synthesis. Examine key innovations and workflow insights to maximize resources and control long-term manufacturing costs.
From Readiness To Results: Unlocking Capacity For Expanding Product Demand
Learn the six pillars that bridge operational readiness and operational excellence. Discover a proven framework to build a resilient, high-performing manufacturing operation and unlock necessary capacity.
Advancing Topical Formulations With Innovative Preclinical Models
A robust formulation development approach integrates scientific principles, systematic formulation development, and preclinical models to facilitate early identification of candidates with poor developability.
Accelerate Your pDNA And mRNA Process Development
Explore a structured approach to optimizing and scaling plasmid DNA production using E. coli, with insights into key growth parameters, benchtop feasibility, and pilot-scale performance.
Driving Robust Tech Transfer In Biologics: Computational Fluid Dynamics (CFD) Simulation
Computational Fluid Dynamics simulation is essential for robust biologics tech transfer. See how this predictive tool optimizes critical scale-up processes, reducing risk and expediting time to market.